Tag Archive: drug safety

PV Inspection Update

Pharmacovigilance inspections by health authorities remain a hot topic for pharma companies.

Read More

Brexit and Pharmacovigilance

What effect will Brexit have on the world of Pharmacovigilance?

Read More

Getting Started in Pharmacovigilance – Part 2

In Part 1 we talked about concepts and starting the preparation for job hunting.  Here are the next steps.

Read More

Getting Started in Pharmacovigilance – Part 1

Interested in a career in Pharmacovigilance?

Read More

FDA Guidance on Biosimilar Labeling

Bart Cobert reviews the newly published FDA draft guidance for industry on Labeling for Biosimilar Products.

Read More

Animal Health 101: Key Components of a Veterinary PV Program

As in the human medical sciences field, the world of veterinary PV is constantly evolving. Explore the 4 main components of an animal health PV program.

Read More

The French Phase I Trial Disaster

Bart Cobert discusses the lessons learned from the recent Phase I trial disaster in France.

Read More

FDA Draft Guidance: Best Practices for Communication with FDA during Drug Development – Safety

Bart Cobert reviews the FDA Draft Guidance: Best Practices for Communication with FDA during Drug Development, and how it relates to safety.

Read More

PV Inspections of Contract Service Providers

An update on inspections by governments and health authorities of CROs and other pharma service providers.

Read More

EudraVigilance Stakeholder Change Management Plan

EMA Changes to EudraVigilance (EV), ICSR reporting and SUSAR reporting

Read More

The Experience Matters.

As an industry leader in business process outsourcing, C3i Solutions delivers global, multi-channel engagement solutions. The Experience Matters. Let us show you why.

Contact Us